Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher D. Major
Observed name:
Christopher Major
Institution:
Janssen Research & Development (United States)
Observed institutions:
National Institutes of Health,
Children's Hospital of Philadelphia,
National Institute of Diabetes and Digestive and Kidney Diseases,
National Cancer Institute,
Janssen Research & Development (United States),
University of Pennsylvania
show all 6
OpenAlex ID:
A5111869379
SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7
2004
·
Stacey DaCosta Byfield
, Christopher Major
, et al.
·
Molecular Pharmacology
·
460
Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation
2002
·
Kathleen C. Flanders
, Catherine D. Sullivan
, et al.
·
American Journal Of Pathology
·
306
Interference with Transforming Growth Factor-β/ Smad3 Signaling Results in Accelerated Healing of Wounds in Previously Irradiated Skin
2003
·
Kathleen C. Flanders
, Christopher D. Major
, et al.
·
American Journal Of Pathology
·
177
PDF
Extracellular Mediators in Atherosclerosis and Thrombosis: Lessons From Thrombin Receptor Knockout Mice
2003
·
Christopher D. Major
, Rosemary J. Santulli
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
126
Diacylglycerol Hydrolysis to Arachidonic Acid Is Necessary for Insulin Secretion from Isolated Pancreatic Islets: Sequential Actions of Diacylglycerol and Monoacylglycerol Lipases
1994
·
Robert J. Konrad
, Christopher D. Major
, et al.
·
Biochemistry
·
95
Interleukin-1β Stimulation of c-Jun NH2-Terminal Kinase Activity in Insulin-Secreting Cells
2001
·
Christopher D. Major
, Bryan A. Wolf
·
Diabetes
·
55
Inhibition of phospholipase A2 and insulin secretion in pancreatic islets
1992
·
Robert J. Konrad
, Y. Camille Jolly
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
54
Transient activation of calcium-dependent phospholipase A2 by insulin secretagogues in isolated pancreatic islets
1993
·
Y. Camille Jolly
, Christopher Major
, et al.
·
Biochemistry
·
39
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib
2021
·
Sriram Balasubramanian
, Songbai Wang
, et al.
·
British Journal of Haematology
·
18
Fuel secretagogue stimulation of arachidonic acid accumulation in fresh and cultured pancreatic islets
1993
·
Robert J. Konrad
, Y.Camille Jolly
, et al.
·
Molecular and Cellular Endocrinology
·
16
PDF
Quantitation of the fatty acid composition of phosphatidic acid by capillary gas chromatography electron-capture detection with picomole sensitivity
1994
·
Christopher Major
, Bryan A. Wolf
·
Journal of Chromatography B Biomedical Sciences and Applications
·
15
Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment
2020
·
Songbai Wang
, Mike Burgess
, et al.
·
The Journal of Pathology Clinical Research
·
13
PDF
A randomized phase II study of erdafitinib (ERDA) versus intravesical chemotherapy (IC) in patients with high-risk nonmuscle invasive bladder cancer (HR-NMIBC) with FGFR mutations or fusions, who recurred after Bacillus Calmette-Guérin (BCG) therapy.
2020
·
Gary D. Steinberg
, Joan Palou-Redorta
, et al.
·
Journal of Clinical Oncology
·
12
Abstract 4010: Analytical concordance of 3 independent diagnostic assays for the detection of FGFR alterations in urothelial carcinoma tumor tissue
2022
·
Christopher Major
, Songbai Wang
·
Cancer Research
·
3
Cytokines and type 1 diabetes: Role of cytokine mediated signal transduction pathways in pancreatic beta cell dysfunction
2000
·
Christopher Major
·
Scholarly Commons (University of Pennsylvania)
Show more works
View as search
Works count:
15
Citation count:
1,389
H-index:
12
I10-index:
13
Year
Topic
Type